Manulife (Manufacturers Life Insurance)
CERE

Manulife (Manufacturers Life Insurance)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,450
Closed -$305K – 3075
2024
Q2 		$305K Sell
7,450
-24,608
-77% -$1.02M ﹤0.01% 2415
2024
Q1 		$1.36M Sell
32,058
-4,776
-13% -$201K ﹤0.01% 1683
2023
Q4 		$1.56M Sell
36,834
-122,137
-77% -$3.51M ﹤0.01% 1566
2023
Q3 		$3.47M Buy
158,971
+12,875
+9% +$322K ﹤0.01% 1266
2023
Q2 		$4.64M Buy
146,096
+18,685
+15% +$573K ﹤0.01% 1121
2023
Q1 		$3.11M Buy
127,411
+5,572
+5% +$164K ﹤0.01% 1259
2022
Q4 		$3.85M Buy
121,839
+3,673
+3% +$104K ﹤0.01% 1180
2022
Q3 		$3.3M Buy
118,166
+3,843
+3% +$114K ﹤0.01% 1234
2022
Q2 		$3.07M Buy
114,323
+4,938
+5% +$140K ﹤0.01% 1318
2022
Q1 		$3.7M Buy
109,385
+89,596
+453% +$2.62M ﹤0.01% 1328
2021
Q4 		$650 Sell
19,789
-265
-1% -$9.35K ﹤0.01% 2093
2021
Q3 		$592K Sell
20,054
-123
-0.6% -$3.45K ﹤0.01% 2165
2021
Q2 		$517K Buy
+20,177
New +$289K ﹤0.01% 2403

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CERE Position: Q3 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,450 shares — an estimated $305K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $4.64M in Q2 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 7,450 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $305K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Manulife (Manufacturers Life Insurance)'s Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $4.64M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2024, filed 13 Nov 2024.